A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2006
12/27/2006	CN1291715C Pharmaceutical compositions containing epinastine and pseudoephedrine
12/27/2006	CN1291713C Novel composition with taxane as major component
12/27/2006	CN1291711C Industrial producing process for breath refreshing tablet
12/27/2006	CN1291710C Dripping pills preparation and its preparing process
12/27/2006	CN1291709C Sugar-free type blood-fat-lowering granule, and its preparation method
12/27/2006	CN1291703C Method and apparatus for improved administration of pharmaceutically active compounds
12/27/2006	CN1291663C Black nightshade health product and its preparation method and uses
12/26/2006	US7154001 Formate salt of O-desmethyl-venlafaxine
12/26/2006	US7153933 Solid phase method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same
12/26/2006	US7153845 Sustained release of testosterone
12/26/2006	US7153840 Aqueous fludarabine phosphate composition
12/26/2006	US7153838 Pharmacologically acceptable solvent vehicles
12/26/2006	US7153834 A homogeneous cyclosporin solution comprising a carrier dialkyl ester of aliphatic or aromatic dioic acid, hydrophilic lipophilic balance, forming emulsions in stomach with gastrointestinal fluids
12/26/2006	US7153538 Method and apparatus for the coating of substrates for pharmaceutical use
12/26/2006	US7153527 Iodine-propylene glycol teat dip
12/26/2006	US7153526 Diagnosing bacteria infections; administering aqueou solution of silver colloids
12/26/2006	US7153525 forming oil in water emulsions containing drugs by heating nanostructure particle size matrices, surfactants and drugs, then cooling while stirring
12/26/2006	US7153524 administering polyethylene glycol or ethylene oxide-propylene oxide copolymers, with drugs, to improve delivery in the alimentary canal
12/26/2006	US7153523 Biologically absorbable polyhydroxycarboxylic acid and production method thereof
12/26/2006	US7153522 bases comprising isoprene-styrene block copolymer and/or polyisobutylene, softeners and tackifier resins, hexylene glycol and 1-menthol as skin absorption intensifiers, and hormones as the drug components
12/26/2006	US7153521 Composition comprising a liquid absorbed on a support based on precipitated silica
12/26/2006	US7153520 Composition for sustained delivery of hydrophobic drugs and process for the preparation thereof
12/26/2006	US7153519 Implantable substrate coated with a macromer having free radical polymerizable substituents
12/26/2006	US7153518 Processed soft tissue for topical or internal application
12/26/2006	US7153514 Use of botulinum toxin therapy for prostatic hyperplasia and related disorders
12/26/2006	US7153513 West nile vaccine
12/26/2006	US7153497 Exhibiting constant release rate and delayed release profiles
12/26/2006	US7153492 prophylactic or wound-healing treatment of lactating animals prone to develop or suffering from mastitis; chitosan, its derivatives and salts thereof and a second component capable of releasing CO2 in an acidic environment
12/26/2006	US7153490 Liposomes encapsulating anticancer drugs and use thereof in the treatment of malignant tumors
12/26/2006	US7153118 Tablet press machine
12/21/2006	WO2006135846A2 Methods and systems for neural maintenance and regeneration
12/21/2006	WO2006135696A2 Method for handling adhesive laminate sections
12/21/2006	WO2006135693A2 Direct compression formulation of dpp-iv inhibitors and glitazones, and process
12/21/2006	WO2006135506A2 Compositions for topical enzymatic debridement
12/21/2006	WO2006135491A2 Medicament carrier composition and method of forming a film therefrom
12/21/2006	WO2006135480A2 Oral pharmaceutical formulations comprising fenofibric acid and/or its salts
12/21/2006	WO2006135373A2 Nano-particle production
12/21/2006	WO2006135362A1 Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs
12/21/2006	WO2006134970A1 Coenzyme q10-containing water-soluble composition and process for production thereof
12/21/2006	WO2006134877A1 Injection
12/21/2006	WO2006134864A1 Solubilization preparation
12/21/2006	WO2006134611A1 Compositions of antiulcerative substituted benzimidazoles
12/21/2006	WO2006134610A1 Efavirenz pharmaceutical composition having enhanced dissolution profile
12/21/2006	WO2006134604A1 Combination composition of cholesterol absorption inhibitor and 3-hydroxy-3-methylglutaryl-coenzyme a (hmg-coa) reductase inhibitor
12/21/2006	WO2006134279A2 Method for solubilizing metronidazole
12/21/2006	WO2006134272A1 Pharmaceutical composition comprising an organopolysiloxane elastomer and a solubilized active principle
12/21/2006	WO2006134018A2 Oral dosage form comprising an antimisuse system
12/21/2006	WO2006133954A2 Diclofenac formulations and methods of use
12/21/2006	WO2006133733A1 Oral dosage form comprising an antimisuse system
12/21/2006	WO2006133612A1 A chinese medicine capsule formulation for treating stroke and preparation method thereof
12/21/2006	WO2006133519A1 Particles comprising a releasable dopant therein
12/21/2006	WO2006133518A1 Particles having hydrophobic material therein
12/21/2006	WO2006120469A3 Therapeutic sclerosing foam made preferably xenon
12/21/2006	WO2006117422A3 Method of preparing micro- and nanometric particles with labile products
12/21/2006	WO2006114604A3 Water-soluble films comprising nicotine
12/21/2006	WO2006103702A3 Enhanced bio-adherent polymeric compositions for coating mucosal and epidermal epithelium
12/21/2006	WO2006103685A3 A method for cultivating cells derived from corneal limbal tissue and cells deived from corneal limbal tissue
12/21/2006	WO2006103407A3 New pharmaceutical compositions useful in the treatment of migraine
12/21/2006	WO2006103112A3 Method for treating prostate diseases based on local delivery of active substances
12/21/2006	WO2006102446A3 Multi-particulate, modified-released colonic composition
12/21/2006	WO2006099865A3 Tablet-type controlled-release preparation containing cinnarizine and dimenhydrinate for combating vertigo
12/21/2006	WO2006097793A3 Compositions capable of facilitating penetration across a biological barrier
12/21/2006	WO2006097725A3 Pharmaceutical compositions comprising microparticles for delivery into neurons
12/21/2006	WO2006094144A3 Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis
12/21/2006	WO2006092812A3 Rapidly disintegrating dosage form comprising magnesium carbonate heavy
12/21/2006	WO2006090149A3 Nasal delivery device
12/21/2006	WO2006089656A3 Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
12/21/2006	WO2006086065A3 Formula, system and method for treating urushiol induced contact dermatitis
12/21/2006	WO2006079019A3 Therapeutic peptide formulations for coating microneedles with improved stabitity containing at least one counterion
12/21/2006	WO2006076222A3 Pharmaceutical formulations
12/21/2006	WO2006075995A3 Article inhibiting microbial growth in physiological fluids
12/21/2006	WO2006071796A3 Pulmonary surfactant formulations
12/21/2006	WO2006071674A3 Oral care compositions containing a eucalyptus extract
12/21/2006	WO2006050002A3 Compositions for controlled delivery of pharmaceutically active compounds
12/21/2006	WO2006037948A3 Methods and kits for delivering drugs by nebulisation
12/21/2006	WO2006022996A3 Dosage form containing multiple drugs
12/21/2006	WO2006014979A3 Palm fiber-based dietary supplements
12/21/2006	WO2006012334A3 Color compositions and methods of using the same
12/21/2006	WO2006010155A3 Gonadotropin releasing hormone antagonists
12/21/2006	WO2005118009A3 Transdermal delivery system for treatment of cognitive disorders
12/21/2006	WO2005105037A8 Use of a viscoelastic composition for treating increased intraocular pressure
12/21/2006	WO2005099666A3 Delayed release formulations of 6-mercaptopurine
12/21/2006	WO2005070444A3 Methods for treating acute myocardial infarction by calcitonin gene related peptide and compositions containing the same
12/21/2006	US20060287689 Cochlear implant drug delivery device
12/21/2006	US20060287611 Administration of therapeutic or diagnostic agents using interlabial pad
12/21/2006	US20060287542 Non-ionic surfactants for solubilizing poorly solubule molecules
12/21/2006	US20060287352 Modified release compositions comprising tacrolimus
12/21/2006	US20060287346 Pharmaceutical formulation comprising a pyrimidine-a-one derivative coated with an enteric polymer
12/21/2006	US20060287225 injecting an alpha-v. beta 3 or alpha-v, beta 5 inhibitor into the vitreous body of the eye; angiogenesis inhibition; diabetic retinopathy, macular degeneration, myopia, ocular histoplasmosis; (2S)-2-benzyloxycarboxamido-3-(2-guanidinomethyl-1,4-benzodioxan-6-yl)propionic acid
12/21/2006	US20060286175 Surfactant- and detergent-free with a continuous liquid phase containing the nanoparticles and a dispersed phase containing one or more medicament particles; phases do not separate due to flocculation or agglomeration
12/21/2006	US20060286174 non-coated complex particulate comprising ion consisting of a styrene-divinylbenzene sulfonic acid cationic exchange resin and a pharmaceutically active material such as oxycodone hydrochloride, tramadol hydrochloride complexed with ion exchange resin; avoids use of coatings and large amounts of solvents
12/21/2006	US20060286173 Drug delivery system for sub-tenon s capsule adminstration of fine grains
12/21/2006	US20060286172 Pharmaceutical compositions comprising prostanoid-receptor agonists and methods of making and using the same
12/21/2006	US20060286169 Lipophilic compositions
12/21/2006	US20060286168 Process for producing coated preparation
12/21/2006	US20060286167 Compositions and methods for the treatment of neurodegenerative diseases
12/21/2006	US20060286166 90% of the particles have a particle size of less than about 40 microns; have profound effects on the ease and reproducibility of formulation
12/21/2006	US20060286165 Taste-masked pharmaceutical particle, the preparation and use thereof
12/21/2006	US20060286164 Pharmaceutical composition containing a stable and clear solution of anti-inflammatory drug in soft gelatin capsule and process for producing the same
12/21/2006	US20060286163 Pharmaceutical composition of topiramate

1 ... 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 ... 2991